AI Calls and Monitors COVID-19 Vaccine Adverse Reaction Reporters, Provides Response Guidance
Dobong-gu October Pilot Program Receives High Satisfaction... Seoul City-SKT Sign Business Agreement
[Asia Economy Reporter Lim Cheol-young] Seoul City announced on the 6th that it will introduce the 'Vaccine Care Call,' an AI telephone guidance service for adverse reactions after COVID-19 vaccination, to enable rapid monitoring of adverse reactions and reduce the workload of autonomous districts. The service will be initially implemented in 13 districts starting in December and then expanded to all districts.
The 'Vaccine Care Call' service is a system where public health center staff input information about individuals reporting adverse reactions after vaccination, and SK Telecom's AI 'NUGU' calls them to monitor symptoms such as ▲pain ▲fever ▲muscle pain ▲headache.
If the reported adverse reaction appears sensitive or severe, the staff will call the individual directly. The content of the calls with those reporting adverse reactions is organized by AI according to the type of reaction, allowing public health center staff to review it. This monitoring of discomfort after vaccination enables rapid response to adverse reactions.
The 'Vaccine Care Call' service is outbound only, with phone numbers assigned per district in the '010-4700-9XXX' range. When calling these numbers, the caller is directed to the district staff's contact number. For this service, Seoul City signed a business agreement with SK Telecom on November 26 to provide the AI telephone guidance service for adverse reactions after vaccination.
Earlier, Seoul City conducted a pilot project of the Vaccine Care Call in Dobong-gu in October. As a result, 3,141 adverse reaction reports were handled, and the number of calls made directly by staff, which was over 100 per day, decreased significantly, leading to high satisfaction among staff. Additionally, before the AI call, a text message was sent to inform recipients about the AI call, and there were no special complaints.
Moreover, the Vaccine Care Call’s high conversational recognition rate (96.2%) and excellent service quality resulted in call interruptions occurring only about 2% of the time, directly helping reduce staff workload. Seoul City plans to share monthly performance analysis data with the 12 districts that have not yet applied out of the 25 districts and encourage continuous participation to expand the service to all districts in Seoul.
Park Yumi, Director of the Seoul City Citizen Health Bureau, said, "Through this agreement, rapid monitoring using artificial intelligence is possible, and the work of staff who previously conducted telephone consultation monitoring can be operated more efficiently. At the same time, we expect faster responses to those experiencing adverse reactions."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
